The Woodstock Hospital is one of the sites participating in a randomized, controlled trial. They are recruiting, and following patients who are enrolled from Oxford County.
WOODSTOCK - A new clinical study is being done out of The Woodstock Hospital. The Anti-Coronavirus Therapies to Prevent Progression of COVID-19 (ACT) study is a Canadian, multi-centre, randomized controlled trial (RCT).
The study went live on June 1st with any patient who tested positive two weeks prior or after June 1 contacted. Woodstock Hospital is one of the sites participating in recruiting, randomizing and following patients who are enrolled from Oxford County. It is led by Population Health Research Institute affiliated with Hamilton Health Sciences and McMaster University.
The outpatient portion of the study looks at a combination of medications linked to help address the inflammation and thrombotic effects of the Coronavirus detected in patients that show signs of the infection.
The regimens of the study may change as as data surfaces, because it is an adaptive study. The principal researcher for the hospital is Emergency physician, Dr. Kashif Ahmed. Southwest Public Health Unit is also assisting Woodstock Hospital with recruiting patients. When the Health Unit contacts patients to tell them their test for COVID-19 is positive, they will ask their consent to allow the hospital research team to contact them about the study.
The study is a high standard of research and will provide doctors clear evidence on whether or not this drug combination is successful.
The medical community will await the results of the randomized controlled trial to evaluate the effects of these drugs on COVID-19.
The results could determine if they can be used to improve patient outcomes including preventing death, preventing hospital admission, and preventing the need for life support treatment.